Lung Cancer  

Know Your Risk!

Lung cancer is by far the leading cause of cancer death among both men and women, making up almost 25% of all cancer deaths. Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.

According to the American Cancer Society estimates, in the year 2020 there will be

  • About 228,820 new cases of lung cancer (116,300 in men and 112,520 in women)
  • About 135,720 deaths from lung cancer (72,500 in men and 63,220 in women)

Risk Factors:

  • Smoking and exposure to tobacco smoke: Smokers and people with regular exposure of second-hand smoking are at a high risk of lung cancer. Nearly 80% of lung cancer deaths are related to smoking. Incidence of small cell lung cancer (SCLC) among non-smokers is very rare5.
  • Exposure to radon: Radonis a naturally occurring radioactive gas that results from the breakdown of uranium in soil and rocks. It is the leading cause of lung cancer among non-smokers.
  • Occupational risks: Exposure to gases, fumes and dusts such as asbestos dusts over prolonged periods of time can increase the risks of lung cancer.
  • Personal or family history: Gene changes that either inherited or acquired during the lifetime could lead to higher risk of lung cancer.

Who Should Consider Screening?

  • Individuals between the ages of 55-80 years
  • 30 pack year or more of smoking history
  • Current smoker or has quit within the last 15 years
  • Patients with a history of lung cancer (treated >5 years ago), or individuals at an increased risk of lung cancer
  • Individuals with chronic obstructive pulmonary disease (COPD) and occupational hazards (exposure to asbestos)

The HALO Dx Approach

We use low-dose CT screening to diagnose lung cancers.

  1. Safety: Low-dose CT is very safe and gives off 90% less radiation compared to conventional CT. Also, it does not require any contrast agents.
  2. Accuracy and details: Low-dose CT provides detailed and accurate information compared to other conventional methods like X-ray. A study conducted by the National Lung Screening Trial Research Team (NLST) has shown that screening with LDCT reduces the risk of lung cancer deaths by 20%
  3. Speed: It takes relatively less time (total time, 10 minutes) and is convenient for patients.
Lung

Schedule a Consultation